Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check4 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check11 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedThe record history now shows a new revision entry for the study (v3.7.0), indicating an updated version of the record compared to the prior revision.SummaryDifference0.1%

- Check53 days agoChange DetectedNew revision entry v3.6.6 is added to the study record history, and the previous revision v3.6.5 is removed. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

- Check74 days agoChange DetectedA new revision entry v3.6.5 was added to the study record history and the previous revision v3.6.4 was removed, updating the visible version history of the page.SummaryDifference0.1%

- Check88 days agoChange DetectedA new release version (v3.6.4) was added to the page’s history. The previous version (v3.6.3) was removed, signaling a minor platform update reflected in the record history.SummaryDifference0.1%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.